Dermatology - European Medical Journal

Continue

Dermatology

Filter
6 May 2022

Understanding the Link Between Eczema and Mental Health

New research has shed light on the close link between the common form of atopic dermatitis, eczema, and incidence of anxiety and depression…
1 Apr 2022

Could Topical Antifungals Result in Foot Dermatitis?

Recent research has shown that foot antifungals prescribed for infections could be a causing factor of foot dermatitis…
1 Apr 2022

New Literature Improving Clinical Understanding of Retronychia

Novel insights into retronychia have provided clinical clarity for healthcare professionals, allowing accurate diagnosis of the condition…
5 Jan 2022

Novel Effective Treatment Approach to Graft-Versus-Host-Disease

Research has demonstrated that the use of dual cytokine blockers can mitigate toxic reactions, including graft-versus-host-disease…
5 Jan 2022

Could a High-Fibre Diet Improve Responses to Cancer Treatment?

New research has revealed that a high-fibre diet has been linked to an increased progression-free survival (PFS) in patients with melanoma…
4 Oct 2021

Are Gut Microorganisms the Key to Healthier Skin?

IMBALANCE in the gut’s microbiome, caused by a diet high in sugar and fats, may contribute to inflammatory skin diseases such as psoriasis…
4 Oct 2021

Could Enzyme Treatments Unlock the Secrets of the Skin Microbiome?

NEW research methodologies, which take advantage of enzymes in order to breakdown bacteria living on human skin, have revealed novel…
2 Jul 2021

Ruxolitinib Cream Effective for Patients with Atopic Dermatitis

A study by Kim Papp looked at ruxolitinib as a topical cream for AD. Ruxolitinib works by inhibiting JAK1 and JAK2 on the cell surface and consequently affects the signalling cascade that would eventually produce pro-inflammatory cytokines.
We’ve noticed you’re accessing
from North/South America.